Hematologic Malignancies

Showing 101 - 125 of 136

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Compare Two Types of Transplant in Adult Hematologic

Unknown status
  • Hematologic Malignancies
  • transplantation
  • (no location specified)
Mar 5, 2015

Hematologic Malignancies, Solid Tumors Trial in Amsterdam (omacetaxine mepesuccinate)

Completed
  • Hematologic Malignancies
  • Solid Tumors
  • omacetaxine mepesuccinate
  • Amsterdam, Netherlands
    Teva Investigational Site 38045
Jan 29, 2015

Hematologic Malignancies Trial in Seoul (ramosetron)

Unknown status
  • Hematologic Malignancies
  • Seoul, Korea, Republic of
    Catholic Blood & Marrow Transplantation Center, Seoul St Mary's
Dec 5, 2014

Depletion of Haplotype Mismatched Alloreactive T Cells

Withdrawn
  • Hematologic Malignancies
  • Hematopoietic Stem Cell Transplantation
  • collection of peripheral blood and apheresis samples
  • (no location specified)
Sep 18, 2014

Hematologic Malignancies Trial in Indianapolis (clofarabine)

Completed
  • Hematologic Malignancies
  • Indianapolis, Indiana
    Indiana University Cancer Center
Sep 17, 2014

GVHD, Hematologic Malignancies Trial (drug, other, procedure)

Completed
  • Graft Versus Host Disease
  • Hematologic Malignancies
  • (no location specified)
Sep 12, 2014

Hematologic Diseases, Hematologic Malignancies Trial in Atlanta (Granulocyte Colony Stimulating Factor)

Completed
  • Hematologic Diseases
  • Hematologic Malignancies
  • Granulocyte Colony Stimulating Factor
  • Atlanta, Georgia
    Children's Healthcare of Atlanta/Emory University
Aug 19, 2014

Hematologic Malignancies Trial in Tampa (Pentostatin, Busulfan, Rituximab)

Completed
  • Hematologic Malignancies
  • Tampa, Florida
    H. Lee Moffitt Cancer Center & Research Institute
May 30, 2014

Hematologic Malignancies Trial in Germany (Fludarabine, Thiotepa, Melphalan)

Completed
  • Hematologic Malignancies
  • Dresden, Germany
  • +6 more
May 28, 2014

Hematologic Malignancies, GVHD Trial in Ann Arbor, St. Louis (reduced intensity, related donor stem cell transplant, tacrolimus

Completed
  • Hematologic Malignancies
  • Graft vs Host Disease
  • reduced intensity, related donor stem cell transplant
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Mar 5, 2014

Cord Blood Stem Cell Transplantation, Hematologic Malignancies Trial in United States (Cord blood transplantation)

Completed
  • Cord Blood Stem Cell Transplantation
  • Hematologic Malignancies
  • Cord blood transplantation
  • Duarte, California
  • +9 more
Mar 7, 2014

Hematologic Malignancies Trial in Charlottesville (drug, radiation, biological)

Terminated
  • Hematologic Malignancies
  • Charlottesville, Virginia
    University of Virginia
Feb 10, 2014

Hematologic Malignancies Trial in Duluth, Durham (CAMPATH (alemtuzumab))

Terminated
  • Hematologic Malignancies
  • CAMPATH (alemtuzumab)
  • Duluth, Minnesota
  • +1 more
Feb 4, 2014

Hematologic Malignancies Trial in Italy, United States (PF-04449913)

Completed
  • Hematologic Malignancies
  • La Jolla, California
  • +5 more
Dec 8, 2013

Hematologic Malignancies, Multiple Myeloma, Lymphoma Trial in Atlanta, Buffalo (MLN4924)

Completed
  • Hematologic Malignancies
  • +3 more
  • Atlanta, Georgia
  • +1 more
Nov 15, 2013

Hematologic Malignancies, Allogeneic Stem Cell Transplantation Trial in Boston (Fludarabine, Melphalan, Antithymocyte Globulin)

Completed
  • Hematologic Malignancies
  • Allogeneic Stem Cell Transplantation
  • Boston, Massachusetts
  • +1 more
Oct 7, 2013

Hematologic Malignancies, AML Trial in Worldwide (CP-4055)

Completed
  • Hematologic Malignancies
  • AML
  • Valhalla, New York
  • +15 more
Sep 12, 2013

Hematologic Malignancies Trial in Boston (Bortezomib (Velcade), Tacrolimus, Methotrexate)

Completed
  • Hematologic Malignancies
  • Bortezomib (Velcade)
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jun 19, 2013

Hematologic Diseases, Hematologic Malignancies Trial in Montreal (Donor lymphocyte preparation depleted of functional host

Completed
  • Hematologic Diseases
  • Hematologic Malignancies
  • Donor lymphocyte preparation depleted of functional host alloreactive T-cells (ATIR)
  • Montreal, Quebec, Canada
    Maisonneuve-Rosemont Hospital
Jun 19, 2013

Hematologic Malignancies Trial in Durham (Non-neutropenic Diet)

Completed
  • Hematologic Malignancies
  • Non-neutropenic Diet
  • Durham, North Carolina
    Duke University Medical Center
May 8, 2013

Hematologic Malignancies Trial in Houston (Cloretazine, Fludarabine)

Completed
  • Hematologic Malignancies
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 27, 2012

Transplantation Using Umbilical Cord Blood and Human

Unknown status
  • Hematologic Malignancies
  • UCB and HPDSC
  • New Orleans, Louisiana
    Louisiana State University Children's Hospital
Apr 9, 2012

Hematologic Malignancies Trial in Atlanta (Busulfan, Cyclophosphamide and Fludarabine)

Completed
  • Hematologic Malignancies
  • Busulfan, Cyclophosphamide and Fludarabine
  • Atlanta, Georgia
    Emory Universtiy Winship Cancer Institute
Apr 5, 2012

Hematologic Malignancies Trial in Australia, Canada, Korea, Republic of (GSK21110183)

Completed
  • Hematologic Malignancies
  • Sydney, New South Wales, Australia
  • +3 more
Apr 3, 2012